Pharma merger task force seeks public comment

Competition law enforcers from multiple jurisdictions are seeking public comment on their review of how to best update approaches to analyzing the effects of pharmaceutical deals....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at